Literature DB >> 17499941

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.

Helen J Ball1, Angeles Sanchez-Perez, Silvia Weiser, Christopher J D Austin, Florian Astelbauer, Jenny Miu, James A McQuillan, Roland Stocker, Lars S Jermiin, Nicholas H Hunt.   

Abstract

Indoleamine 2,3-dioxygenase (INDO) and tryptophan 2,3-dioxygenase (TDO) each catalyze the first step in the kynurenine pathway of tryptophan metabolism. We describe the discovery of another enzyme with this activity, indoleamine 2,3-dioxygenase-like protein (INDOL1), which is closely related to INDO and is expressed in mice and humans. The corresponding genes have a similar genomic structure and are situated adjacent to each other on human and mouse chromosome 8. They are likely to have arisen by gene duplication before the origin of the tetrapods. The expression of INDOL1 is highest in the mouse kidney, followed by epididymis, and liver. Expression of mouse INDOL1 was further localized to the tubular cells in the kidney and the spermatozoa. INDOL1 was assigned its name because of its structural similarity to INDO. We demonstrate that INDOL1 catalyses the conversion of tryptophan to kynurenine therefore a more appropriate nomenclature for the enzymes might be INDO-1 and INDO-2, or the more commonly-used abbreviations, IDO-1 and IDO-2. Although the two proteins have similar enzymatic activities, their different expression patterns within tissues and during malaria infection, suggests a distinct role for each protein. This identification of INDOL1 may help to explain the regulation of the diversity of physiological and patho-physiological processes in which the kynurenine pathway is involved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499941     DOI: 10.1016/j.gene.2007.04.010

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  158 in total

Review 1.  Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Authors:  G C Prendergast; M Y Chang; L Mandik-Nayak; R Metz; A J Muller
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion.

Authors:  Alexander J Muller; James B DuHadaway; Mee Young Chang; Arivudinambi Ramalingam; Erika Sutanto-Ward; Janette Boulden; Alejandro P Soler; Laura Mandik-Nayak; Susan K Gilmour; George C Prendergast
Journal:  Cancer Immunol Immunother       Date:  2010-07-17       Impact factor: 6.968

3.  The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation.

Authors:  Pei H Cui; Nenad Petrovic; Michael Murray
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

4.  Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.

Authors:  Paul B Larkin; Korrapati V Sathyasaikumar; Francesca M Notarangelo; Hiroshi Funakoshi; Toshikazu Nakamura; Robert Schwarcz; Paul J Muchowski
Journal:  Biochim Biophys Acta       Date:  2016-07-05

5.  Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state.

Authors:  Aicha Jrad-Lamine; Joelle Henry-Berger; Pascal Gourbeyre; Christelle Damon-Soubeyrand; Alain Lenoir; Lydie Combaret; Fabrice Saez; Ayhan Kocer; Shigenobu Tone; Dietmar Fuchs; Wentao Zhu; Peter J Oefner; David H Munn; Andrew L Mellor; Najoua Gharbi; Rémi Cadet; R John Aitken; Joël R Drevet
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

6.  Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouse.

Authors:  Manuela Schmid; Maik J Lehmann; Richard Lucius; Nishith Gupta
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

7.  Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.

Authors:  Jason C O'Connor; Marcus A Lawson; Caroline André; Eileen M Briley; Sandra S Szegedi; Jacques Lestage; Nathalie Castanon; Miles Herkenham; Robert Dantzer; Keith W Kelley
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

Authors:  Alexander J Muller; Madhav D Sharma; Phillip R Chandler; James B Duhadaway; Mary E Everhart; Burles A Johnson; David J Kahler; Jeanene Pihkala; Alejandro Peralta Soler; David H Munn; George C Prendergast; Andrew L Mellor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

Review 9.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance.

Authors:  Joshua Chiappelli; Ana Pocivavsek; Katie L Nugent; Francesca M Notarangelo; Peter Kochunov; Laura M Rowland; Robert Schwarcz; L Elliot Hong
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.